Dianthus Therapeutics Inc. (DNTH) — Working Capital to Net Assets Ratio
Dianthus Therapeutics Inc. (DNTH) has a Working Capital to Net Assets ratio of 73.6% as of June 2026. Working capital of $863.15 Million (current assets of $897.54 Million minus current liabilities of $34.39 Million) is measured against net assets of $1.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Dianthus Therapeutics Inc. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Dianthus Therapeutics Inc. Working Capital to Net Assets (2016–2025)
This chart shows how Dianthus Therapeutics Inc.'s Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 73.6%, reflecting working capital of $863.15 Million against net assets of $1.17 Billion USD. For the complete balance sheet picture, see DNTH current and non-current assets.
Annual Working Capital to Net Assets for Dianthus Therapeutics Inc. (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Dianthus Therapeutics Inc. from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Dianthus Therapeutics Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.8% | $378.71 Million | $493.40 Million | $409.44 Million | $30.73 Million | ▲ +2.3 pp |
| 2024 | 74.5% | $262.45 Million | $352.48 Million | $280.90 Million | $18.45 Million | ▼ -24.9 pp |
| 2023 | 99.4% | $167.82 Million | $168.87 Million | $177.45 Million | $9.63 Million | ▼ -0.8 pp |
| 2022 | 100.2% | $73.81 Million | $73.66 Million | $82.03 Million | $8.22 Million | ▲ +1.9 pp |
| 2021 | 98.4% | $169.83 Million | $172.67 Million | $180.69 Million | $10.86 Million | ▲ +1.0 pp |
| 2020 | 97.4% | $140.10 Million | $143.91 Million | $151.53 Million | $11.43 Million | ▲ +1.2 pp |
| 2019 | 96.1% | $135.73 Million | $141.19 Million | $149.84 Million | $14.12 Million | ▲ +3.5 pp |
| 2018 | 92.6% | $134.90 Million | $145.65 Million | $145.32 Million | $10.42 Million | ▼ -3.5 pp |
| 2017 | 96.1% | $48.36 Million | $50.32 Million | $52.50 Million | $4.14 Million | ▲ +1.7 pp |
| 2016 | 94.4% | $8.53 Million | $9.04 Million | $10.83 Million | $2.30 Million | — |